{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-160779","form_type":"8-K","ticker":"NTLA","cik":"0001652130","company_name":"Intellia Therapeutics, Inc.","filed_at":"2023-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.852525+00:00","generated_at":"2026-06-14T07:24:30.771329+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Intellia co-founder Jean-François Formela retires from board, effective June 15","bullets":["Jean-François Formela, co-founder and director since 2014, resigns from board effective June 15, 2023.","Resignation not due to any disagreement with Intellia on operations, policies, or practices.","Formela served on Audit and Compensation and Talent Development Committees.","No replacement was announced; board size will decrease upon his departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-160779","json":"https://secwatch.observer/filing/0001193125-23-160779.json","markdown":"https://secwatch.observer/filing/0001193125-23-160779.md","text":"https://secwatch.observer/filing/0001193125-23-160779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652130/000119312523160779/0001193125-23-160779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652130/000119312523160779/d516011d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:24:30.771329+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b65c7104c4","claim":"Jean-François Formela resigned as Director at Intellia Therapeutics, Inc..","evidence_excerpt":"On June 5, 2023, Jean-François Formela notified Intellia Therapeutics, Inc. (the “Company”) of his intent to resign from the Board of Directors (the “Board”) of the Company and its committees, effective June 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312523160779/0001193125-23-160779-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}